Back to search

Progestogen intolerance and compliance with hormone replacement therapy in menopausal women

Data up to Jan 2025

Published1997
Citations115
References61

Total Citations Per Year

Abstract

References (61)

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women

1995 • 2,281 citations

Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence

1991 • 1,603 citations

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1996 • 1,323 citations

Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures

1985 • 788 citations

Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine Devices

1986 • 265 citations

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.

1995 • 224 citations

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy

1993 • 220 citations

The Premenstrual Syndrome and Progesterone Therapy.

1984 • 218 citations

The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome

1986 • 212 citations

CYCLICAL MOOD CHANGES AS IN THE PREMENSTRUAL TENSION SYNDROME DURING SEQUENTIAL ESTROGEN‐PROGESTAGEN POSTMENOPAUSAL REPLACEMENT THERAPY

1985 • 197 citations

Estrogen replacement therapy. A survey of women's knowledge and attitudes

1989 • 196 citations

Endometrial disease after treatment with oestrogens and progestogens in the climacteric.

1980 • 182 citations

Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women

1978 • 170 citations

Role of female gonadal hormones in the CNS: Clinical and experimental aspects

1985 • 165 citations

Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.

1972 • 143 citations

Amenorrhea and Endometrial Atrophy with Continuous Oral Estrogen and Progestogen Therapy in Postmenopausal Women

1985 • 139 citations

ENDOCRINE CHANGES AND SYMPTOMATOLOGY AFTER OOPHORECTOMY IN PREMENOPAUSAL WOMEN

1977 • 138 citations

Five years' experience with levonorgestrel-releasing IUDs

1986 • 132 citations

PREVENTION AND TREATMENT OF ENDOMETRIAL DISEASE IN CLIMACTERIC WOMEN RECEIVING ŒSTROGEN THERAPY

1979 • 125 citations

Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women

1992 • 114 citations

Org OD 14 and the endometrium

1991 • 113 citations

Effects of Progesterone and Four Synthetic Progestagens on Sodium Balance and the Renin-Aldosterone System in Man*†

1974 • 112 citations

Intrauterine release of levonorgestrel - A new way of adding progestogen in hormone replacement therapy

1993 • 111 citations

Cyclic hormone replacement therapy using quarterly progestin.

1994 • 109 citations

Progestogen addition during oestrogen replacement therapy — effects on vasomotor symptoms and mood

1989 • 105 citations

Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.

1983 • 102 citations

Re-evaluating the role of progestogen therapy after the menopause.

1988 • 98 citations

Plasma levels of d-norgestrel after oral administration

1976 • 92 citations

Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: Clinical and endometrial responses

1995 • 91 citations

Enhancing patient compliance with hormone replacement therapy at menopause

1990 • 85 citations

Sustained intrauterine release of levonorgestrel over five years

1986 • 83 citations

A cost‐effectiveness analysis of hormone replacement therapy in the menopause∗

1992 • 83 citations

Clinical experience with tibolone (Livial®) over 8 years

1995 • 81 citations

Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.

1994 • 69 citations

Utilisation of hormone replacement therapy by women doctors

1995 • 65 citations

Continuous low‐dose oestrogen and progestogen hormone replacement therapy: a randomised trial

1993 • 59 citations

A study of the experience of Glasgow women in the climacteric years

1989 • 58 citations

The incidence of vaginal bleeding with tibolone treatment

1994 • 55 citations

A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin

1996 • 55 citations

Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation

1992 • 53 citations

Endocrinology: The effect of high-dose medium- and long- term progestogen exposure on endometrial vessels

1995 • 51 citations

Uterus and endometrium: Effect of high dose progestogens on white cells and necrosis in human endometrium

1996 • 51 citations

Long-term follow-up of women treated with NORPLANTR implants

1987 • 46 citations

Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy

1995 • 43 citations

Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.

1985 • 40 citations

Morphometric, immunohistological and threedimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone

1996 • 40 citations

Progestogens: therapeutic and adverse effects in early post-menopausal women

1991 • 38 citations

Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone

1990 • 37 citations

HRT: Developments in therapy

1992 • 33 citations

The effect of intrauterine progesterone on the hypothalamic-hypophyseal-ovarian axis in humans

1975 • 29 citations

Dose-response effects on serum lipids and lipoproteins following combined oestrogenprogestogen therapy in post-menopausal women

1987 • 28 citations

Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device

1995 • 27 citations

The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy

1994 • 27 citations

The symptomatology of progestogen intolerance

1994 • 26 citations

Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone

1986 • 25 citations

PROLONGED FOLLICULAR PHASE AND DEPRESSED GONADOTROPHINS FOLLOWING HYSTERECTOMY AND CORPUS LUTE‐ECTOMY IN WOMEN WITH PREMENSTRUAL TENSION SYNDROME

1985 • 22 citations

A novel oestradiol-desogestrel preparation for hormone replacement therapy: Effects on hormones, lipids, bone, climacteric symptoms and endometrium

1993 • 20 citations

Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation

1993 • 15 citations

Progestogens in Estrogen-Replacement Therapy

1995 • 14 citations

Endometrial Histology, Uterine Bleeding, and Metabolic Changes in Postmenopausal Women Using a Progesterone-Releasing Intrauterine Device and Oral Conjugated Estrogens for Hormone Replacement Therapy

1994 • 6 citations

Endometrial responses to hormone replacement therapy

1998 • 3 citations

Cited By (0)

Loading...